Wuhan Hiteck Biological Pharma Co Ltd Cash Flow-to-Debt Ratio
Wuhan Hiteck Biological Pharma Co Ltd cash flow-to-debt ratio. Wuhan Hiteck Biological Pharma Co Ltd (300683) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-17.49 Million could theoretically repay 0% of its total liabilities (CN¥393.09 Million) in one year. Check 300683 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Wuhan Hiteck Biological Pharma Co Ltd (2013–2025)
Cash flow-to-debt ratio of Wuhan Hiteck Biological Pharma Co Ltd from 2013 to 2025. Historical debt coverage capacity for Wuhan Hiteck Biological Pharma Co Ltd across 13 annual periods. Check Wuhan Hiteck Biological Pharma Co Ltd (300683) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Wuhan Hiteck Biological Pharma Co Ltd Cash Flow-to-Debt Ratio by Year (2013–2025)
Wuhan Hiteck Biological Pharma Co Ltd cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Wuhan Hiteck Biological Pharma Co Ltd. For the full cash flow conversion analysis, see Wuhan Hiteck Biological Pharma Co Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.19x | CN¥-76.54 Million | CN¥407.14 Million | ▼ -535.1% |
| 2024 | 0.04x | CN¥22.69 Million | CN¥525.05 Million | ▲ +286.8% |
| 2023 | 0.01x | CN¥5.31 Million | CN¥475.73 Million | ▼ -92.2% |
| 2022 | 0.14x | CN¥53.03 Million | CN¥371.20 Million | ▲ +318.9% |
| 2021 | 0.03x | CN¥12.09 Million | CN¥354.46 Million | ▲ +179.9% |
| 2020 | -0.04x | CN¥-19.70 Million | CN¥461.62 Million | ▼ -127.7% |
| 2019 | 0.15x | CN¥63.03 Million | CN¥409.03 Million | ▼ -6.4% |
| 2018 | 0.16x | CN¥73.42 Million | CN¥445.77 Million | ▼ -47.3% |
| 2017 | 0.31x | CN¥83.08 Million | CN¥265.62 Million | ▼ -27.0% |
| 2016 | 0.43x | CN¥143.86 Million | CN¥335.87 Million | ▼ -26.1% |
| 2015 | 0.58x | CN¥159.89 Million | CN¥275.74 Million | ▲ +13.4% |
| 2014 | 0.51x | CN¥135.40 Million | CN¥264.78 Million | ▲ +24.1% |
| 2013 | 0.41x | CN¥76.82 Million | CN¥186.42 Million | — |